本季度信息
华润医药于2026年4月24日公布旗下子公司华润三九截至2026年3月31日止三个月的财务数据显示，营收为81.30亿元（去年同期为68.54亿元），同比增长18.60%。经调整净利润录得12.09亿元（去年同期为13.31亿元），同比下降9.20%。
同期，公司现金及现金等价物减少13.18亿元，而上年同期增加12.47亿元；截至报告期末，现金及现金等价物为31.98亿元。公告同时显示，截至2026年3月31日，总资产为581.42亿元，较上一年末有所下降。
由于公告未披露毛利率、销售及管理费用率、研发投入占比等指标，具体成本结构变化暂无更多信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.